GHRS 3 SEC Filing Analysis

Latest settled — T+20d

GHRS ▲ +40.91% at T+20d

NEUTRAL call ✓ call won +40.91% · α vs SPY +31.03% · entry $14.57 → $20.53

Next anchor: T+60d in 19d

Last close $20.12 (close Jun 8) · +38.09% from $14.57 entry

Entry anchored
Apr 1, 03:59 PM ET
via Databento tick

T+1d

+3.91%

call +3.91% · α +3.44%

$15.14

settled 2mo ago

T+5d

+7.89%

call +7.89% · α +4.27%

$15.72

settled 2mo ago

T+20d

+40.91%

call +40.91% · α +31.03%

$20.53

settled 6w ago

T+60d

—

call — · α —

—

in 19d

Price Chart

Loading chart...

Executive Summary

Florian Schonharting, a reporting person at GH Research PLC, filed a Form 3 to report initial beneficial ownership of 14,824,419 ordinary shares and appointed five individuals as attorneys-in-fact to handle SEC filings and potential share sales on his behalf. This is a routine compliance filing with no immediate financial impact.

Actionable Insight

Monitor future Form 4 filings for any insider transactions by Schonharting, as the Power of Attorney enables delegated share sales. No immediate trading implications, but increased transparency on ownership structure.

Key Facts

Florian Schonharting holds 14,824,419 ordinary shares in GH Research PLC
Filed Form 3 to report initial beneficial ownership as of April 1, 2026
Appointed five individuals (Louise Barrett, Rannagh Morris, Julie Ryan, Magnus Halle, Emma Corcoran) as attorneys-in-fact to execute Forms 3, 4, 5, and Form 144 on his behalf
Power of Attorney granted on March 6, 2026, allows for potential future share sales under Rule 144

Financial Impact

No immediate financial impact. Potential for future share sales exists but not quantified.

insider ownershippotential dilutioninsider selling

Risk Factors

Potential for future insider selling under Rule 144, which could create downward pressure on stock price
Lack of disclosure on whether the shares are held directly or indirectly, affecting ownership clarity

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

Document	Accession Number
3 Filing (Primary)	0001140361-26-012738
Document: 0001140361-26-012738-index-headers.html	0001140361-26-012738
Document: 0001140361-26-012738-index.html	0001140361-26-012738
Document: 0001140361-26-012738.txt	0001140361-26-012738

8 reports for GHRS

T+1T+5T+20T+60

80% Hit rate 4 of 5 directional calls best @ T+60▲ +63.68%Mar 5, 2026

Filters

Reports for GHRS — sortable, filterable
	Type				Now
May 14, 2026 26d ago	424B5 BEARISH ★ 6/10	$22.21 $21.77	▲ +1.98%	▲ +1.26%	$20.12 (+9.41%)
May 14, 2026 26d ago	6-K NEUTRAL ★ 5/10	$22.21 $21.77	▼ −1.98%	▼ −1.26%	$20.12 (−9.41%)
May 14, 2026 26d ago	Press Release MIXED ★ 6/10	$22.21 $21.77	▼ −1.98%	▼ −1.26%	$20.12 (−9.41%)
May 13, 2026 27d ago	6-K BEARISH ★ 6/10	$22.21 $21.77	▲ +1.98%	▲ +1.26%	$20.12 (+9.41%)
Apr 29, 2026 5w ago	424B5 BEARISH ★ 6/10	$19.16 $21.28	▼ −11.06%	▼ −7.95%	$20.12 (−5.01%)
Apr 1, 2026 9w ago	3 NEUTRAL ★ 2/10	$14.57 $15.72	▲ +7.89%	▲ +4.27%	$20.12 (+38.09%)
Mar 25, 2026 10w ago	Press Release BULLISH ★ 8/10	$13.65 $14.72	▲ +7.84%	▲ +8.08%	$20.12 (+47.40%)
Mar 5, 2026 13w ago	Press Release BULLISH ★ 8/10	$15.17 $15.52	▲ +2.31%	▲ +4.54%	$20.12 (+32.63%)

US Market Status

Market Closed — Opens in 7h 7m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access